JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus

NCT05967520 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: JMKX000189
DRUG: Placebo

Sponsor

Jemincare